CX3CL1 promotes breast cancer via transactivation of the EGF pathway
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationTINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptorsA lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors.Effect of Necrosis on the miRNA-mRNA Regulatory Network in CRT-MG Human Astroglioma Cells.Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinibNovel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells.The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma.CX3CL1: a potential chemokine widely involved in the process spinal metastases.APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α.Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity.CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway
P2860
Q26796395-44B40835-FB71-4F59-A176-D58C5830AD21Q30369946-47798B17-FEB7-4533-8631-D5A2417A7181Q35140322-CACD82F7-299E-4932-B903-43C52875EE6DQ37589128-C1A51B12-1160-4BF3-9FCD-9287CCC744A6Q38433156-DFA590F3-627C-4E28-931E-75BE44D2E2F3Q38925880-C94885D2-F997-49D0-B37A-CE3F23428E11Q38961444-2DFE44E7-6573-4969-B02D-B4A9DC43D4BBQ39114003-8380FB68-E343-4185-8946-AD4EA4CEE735Q39899711-0598B4F5-5DF5-4209-8334-BDED734B9900Q41867466-3EE6EFF7-D9ED-4815-A3BA-36F6412040C5Q41962641-D180D1F4-569C-4A34-BE64-1887488EAD87Q42314698-64A44713-5A6F-476D-9F16-5113E839220CQ42473854-416B7F85-16A3-45EB-B148-54620A74C39EQ47100529-82BA1AF5-3F95-4149-8AA0-E29BED3E5B4AQ50107305-285EECEC-4B6C-45C2-A6F3-6239677FCEE7Q51551651-8C3D98CC-BAB1-4B13-82E8-EEA5FDD6CD6DQ57493783-0BC75E27-04BB-4715-8AD3-B3956526D248
P2860
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@ast
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@en
type
label
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@ast
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@en
prefLabel
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@ast
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@en
P2093
P2860
P50
P1433
P1476
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
@en
P2093
Anna M Feijoo
Emilia Mira
Manuel Tardáguila
Santos Mañes
Sergio A Lira
P2860
P304
P356
10.1158/0008-5472.CAN-12-3828
P407
P577
2013-05-29T00:00:00Z